Combination immunotherapy with two attenuated Listeria strains carrying shuffled HPV-16 E6E7 protein causes tumor regression in a mouse tumor model

Abstract Cervical cancer continues to impose a heavy burden worldwide, and human papilloma virus (HPV) infection, especially persistent infection with type 16 (HPV-16), is known to be the primary etiological factor. Therapeutic vaccines are urgently needed because prophylactic vaccines are ineffecti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lin Su, Yunwen Zhang, Xiang Zhang, Ting Liu, Sijing Liu, Yongyu Li, Mingjuan Jiang, Tian Tang, Haiqian Shen, Chuan Wang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3dde4d541fec4fbb901c537c5f212352
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3dde4d541fec4fbb901c537c5f212352
record_format dspace
spelling oai:doaj.org-article:3dde4d541fec4fbb901c537c5f2123522021-12-02T16:31:50ZCombination immunotherapy with two attenuated Listeria strains carrying shuffled HPV-16 E6E7 protein causes tumor regression in a mouse tumor model10.1038/s41598-021-92875-92045-2322https://doaj.org/article/3dde4d541fec4fbb901c537c5f2123522021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-92875-9https://doaj.org/toc/2045-2322Abstract Cervical cancer continues to impose a heavy burden worldwide, and human papilloma virus (HPV) infection, especially persistent infection with type 16 (HPV-16), is known to be the primary etiological factor. Therapeutic vaccines are urgently needed because prophylactic vaccines are ineffective at clearing pre-existing HPV infection. Here, two recombinant Listeria strains (LMΔ-E6E7 & LIΔ-E6E7) with deletions of the actA and plcB genes, expressing the shuffled HPV-16 E6E7 protein were constructed. The strains were delivered into the spleen and liver by intravenous inoculation, induced antigen-specific cellular immunity and were eliminated completely from the internal organs several days later. Intravenously treating with single strain for three times, or with both strains alternately for three times significantly reduced the tumor size and prolonged the survival time of model mice. Combination immunotherapy with two strains seemed more effective than immunotherapy with single strain in that it enhanced the survival of the mice, and the LMΔ-E6E7-prime-LIΔ-E6E7-boost strategy showed significant stronger efficacy than single treatment with the LIΔ-E6E7 strain. The antitumor effect of this treatment might due to its ability to increase the proportion of CD8+ T cells and reduce the proportion of T regulatory cells (Tregs) in the intratumoral milieu. This is the first report regarding Listeria ivanovii-based therapeutic vaccine candidate against cervical cancer. Most importantly we are the first to confirm that combination therapy with two different recombinant Listeria strains has a more satisfactory antitumor effect than administration of a single strain. Thus, we propose a novel prime-boost treatment strategy.Lin SuYunwen ZhangXiang ZhangTing LiuSijing LiuYongyu LiMingjuan JiangTian TangHaiqian ShenChuan WangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Lin Su
Yunwen Zhang
Xiang Zhang
Ting Liu
Sijing Liu
Yongyu Li
Mingjuan Jiang
Tian Tang
Haiqian Shen
Chuan Wang
Combination immunotherapy with two attenuated Listeria strains carrying shuffled HPV-16 E6E7 protein causes tumor regression in a mouse tumor model
description Abstract Cervical cancer continues to impose a heavy burden worldwide, and human papilloma virus (HPV) infection, especially persistent infection with type 16 (HPV-16), is known to be the primary etiological factor. Therapeutic vaccines are urgently needed because prophylactic vaccines are ineffective at clearing pre-existing HPV infection. Here, two recombinant Listeria strains (LMΔ-E6E7 & LIΔ-E6E7) with deletions of the actA and plcB genes, expressing the shuffled HPV-16 E6E7 protein were constructed. The strains were delivered into the spleen and liver by intravenous inoculation, induced antigen-specific cellular immunity and were eliminated completely from the internal organs several days later. Intravenously treating with single strain for three times, or with both strains alternately for three times significantly reduced the tumor size and prolonged the survival time of model mice. Combination immunotherapy with two strains seemed more effective than immunotherapy with single strain in that it enhanced the survival of the mice, and the LMΔ-E6E7-prime-LIΔ-E6E7-boost strategy showed significant stronger efficacy than single treatment with the LIΔ-E6E7 strain. The antitumor effect of this treatment might due to its ability to increase the proportion of CD8+ T cells and reduce the proportion of T regulatory cells (Tregs) in the intratumoral milieu. This is the first report regarding Listeria ivanovii-based therapeutic vaccine candidate against cervical cancer. Most importantly we are the first to confirm that combination therapy with two different recombinant Listeria strains has a more satisfactory antitumor effect than administration of a single strain. Thus, we propose a novel prime-boost treatment strategy.
format article
author Lin Su
Yunwen Zhang
Xiang Zhang
Ting Liu
Sijing Liu
Yongyu Li
Mingjuan Jiang
Tian Tang
Haiqian Shen
Chuan Wang
author_facet Lin Su
Yunwen Zhang
Xiang Zhang
Ting Liu
Sijing Liu
Yongyu Li
Mingjuan Jiang
Tian Tang
Haiqian Shen
Chuan Wang
author_sort Lin Su
title Combination immunotherapy with two attenuated Listeria strains carrying shuffled HPV-16 E6E7 protein causes tumor regression in a mouse tumor model
title_short Combination immunotherapy with two attenuated Listeria strains carrying shuffled HPV-16 E6E7 protein causes tumor regression in a mouse tumor model
title_full Combination immunotherapy with two attenuated Listeria strains carrying shuffled HPV-16 E6E7 protein causes tumor regression in a mouse tumor model
title_fullStr Combination immunotherapy with two attenuated Listeria strains carrying shuffled HPV-16 E6E7 protein causes tumor regression in a mouse tumor model
title_full_unstemmed Combination immunotherapy with two attenuated Listeria strains carrying shuffled HPV-16 E6E7 protein causes tumor regression in a mouse tumor model
title_sort combination immunotherapy with two attenuated listeria strains carrying shuffled hpv-16 e6e7 protein causes tumor regression in a mouse tumor model
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/3dde4d541fec4fbb901c537c5f212352
work_keys_str_mv AT linsu combinationimmunotherapywithtwoattenuatedlisteriastrainscarryingshuffledhpv16e6e7proteincausestumorregressioninamousetumormodel
AT yunwenzhang combinationimmunotherapywithtwoattenuatedlisteriastrainscarryingshuffledhpv16e6e7proteincausestumorregressioninamousetumormodel
AT xiangzhang combinationimmunotherapywithtwoattenuatedlisteriastrainscarryingshuffledhpv16e6e7proteincausestumorregressioninamousetumormodel
AT tingliu combinationimmunotherapywithtwoattenuatedlisteriastrainscarryingshuffledhpv16e6e7proteincausestumorregressioninamousetumormodel
AT sijingliu combinationimmunotherapywithtwoattenuatedlisteriastrainscarryingshuffledhpv16e6e7proteincausestumorregressioninamousetumormodel
AT yongyuli combinationimmunotherapywithtwoattenuatedlisteriastrainscarryingshuffledhpv16e6e7proteincausestumorregressioninamousetumormodel
AT mingjuanjiang combinationimmunotherapywithtwoattenuatedlisteriastrainscarryingshuffledhpv16e6e7proteincausestumorregressioninamousetumormodel
AT tiantang combinationimmunotherapywithtwoattenuatedlisteriastrainscarryingshuffledhpv16e6e7proteincausestumorregressioninamousetumormodel
AT haiqianshen combinationimmunotherapywithtwoattenuatedlisteriastrainscarryingshuffledhpv16e6e7proteincausestumorregressioninamousetumormodel
AT chuanwang combinationimmunotherapywithtwoattenuatedlisteriastrainscarryingshuffledhpv16e6e7proteincausestumorregressioninamousetumormodel
_version_ 1718383865122258944